Hypoxia can promote glioma growth, angiogenesis, and invasion, which is achieved mainly through the hypoxia-inducible factor 1 (HIF-1) pathway to upregulate target genes such as vascular endothelial growth factors (VEGF), VEGF receptors (VEGFR), and MMPs [57]. Here, KDR is linked to central nervous system cancer.